{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:53:31Z","timestamp":1792054411320,"version":"4.4.0"},"reference-count":161,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Applications of nanotechnology for treatment, diagnosis, monitoring, and control of biological systems has recently been referred to as \u201cnanomedicine\u201d by the National Institutes of Health. Research into the rational delivery and targeting of pharmaceutical, therapeutic, and diagnostic agents is at the forefront of projects in nanomedicine. These involve the identification of precise targets (cells and receptors) related to specific clinical conditions and choice of the appropriate nanocarriers to achieve the required responses while minimizing the side effects. Mononuclear phagocytes, dendritic cells, endothelial cells, and cancers (tumor cells, as well as tumor neovasculature) are key targets. Today, nanotechnology and nanoscience approaches to particle design and formulation are beginning to expand the market for many drugs and are forming the basis for a highly profitable niche within the industry, but some predicted benefits are hyped. This article will highlight rational approaches in design and surface engineering of nanoscale vehicles and entities for site\u2010specific drug delivery and medical imaging after parenteral administration. Potential pitfalls or side effects associated with nanoparticles are also discussed.\u2014Moghimi, S. M. Hunter, A. C., Murray, J. C. Nanomedicine: current status and future prospects.\n                    <jats:italic>FASEB J.<\/jats:italic>\n                    19, 311\u2010330 (2005)\n                  <\/jats:p>","DOI":"10.1096\/fj.04-2747rev","type":"journal-article","created":{"date-parts":[[2005,3,3]],"date-time":"2005-03-03T13:47:49Z","timestamp":1109857669000},"page":"311-330","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1655,"title":["Nanomedicine: current status and future prospects"],"prefix":"10.1096","volume":"19","author":[{"given":"S. Moein","family":"Moghimi","sequence":"first","affiliation":[{"name":"Molecular Targeting and Polymer Toxicology Group School of Pharmacy University of Brighton  Brighton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Christy","family":"Hunter","sequence":"additional","affiliation":[{"name":"Molecular Targeting and Polymer Toxicology Group School of Pharmacy University of Brighton  Brighton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Clifford","family":"Murray","sequence":"additional","affiliation":[{"name":"Cancer Research UK Tumour Cytokine Biology Group Wolfson Digestive Diseases Centre University Hospital  Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,3]]},"reference":[{"key":"e_1_2_9_2_1","volume-title":"Introduction to Nanotechnology","author":"Poole C. P.","year":"2003"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0396-303"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja0102639"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000119321.18573.5A"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.200300730"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh191"},{"key":"e_1_2_9_8_1","first-page":"223","article-title":"Comparison of ultrasmall particles of iron oxide (USIOP) -enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis","volume":"20","author":"Dousset V.","year":"1999","journal-title":"Am. J. Neuroradiol."},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022749"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0730-725X(01)00448-9"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.3.415"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000068315.98705.CC"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.2144\/03342bi01"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0958-1669(02)00282-3"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt767"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1083780"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1077194"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc034153y"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt994"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.152463399"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1096"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1088525"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt764"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1095833"},{"key":"e_1_2_9_25_1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi S. M.","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(03)02903-9"},{"key":"e_1_2_9_27_1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissues","volume":"55","author":"Panyam J.","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2003.10.018"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.10397"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1021\/nl025604a"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja0347383"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.200300905"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.200301694"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-3659(95)00169-7"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4914(03)00005-4"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/bm025740"},{"key":"e_1_2_9_37_1","first-page":"153","article-title":"Long-circulating vectors for the systemic delivery of genes","volume":"3","author":"Fenske D. B.","year":"2001","journal-title":"Curr. Opin. Mol. Therap."},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm9911579"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1494"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(95)00122-Y"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc903"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(99)00062-9"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0931428100"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7827(00)00011-4"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0088com"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac990629o"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1020398624602"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7827(03)00033-X"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011054123304"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5769(01)00006-6"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt920"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4889(02)00204-5"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(02)03710-9"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840210130"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(03)02686-2"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.289.5482.1197"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0202-121"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1434429100"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4914(02)02429-2"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature02580"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(02)02501-1"},{"key":"e_1_2_9_62_1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i23.20","article-title":"Endothelial cells as therapeutic targets in cancer: new biology and novel delivery systems","volume":"20","author":"Murray J. C.","year":"2003","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(98)00099-4"},{"key":"e_1_2_9_64_1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0022-3565(24)38903-7","article-title":"Novel method of greatly enhanced delivery of liposomes to lymph nodes","volume":"295","author":"Phillips W. T.","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(03)00273-4"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2004.40.2.799425"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015127225021"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(99)00061-7"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704408"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1080\/13693780310001624583"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200009)43:9<1951::AID-ANR5>3.0.CO;2-K"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(99)00306-1"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3089.2000.00071.x"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200311000-00014"},{"key":"e_1_2_9_75_1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1128\/jvi.71.1.624-629.1997","article-title":"Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ","volume":"71","author":"Wolf G.","year":"1997","journal-title":"J. Virol."},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.8.2834"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature02405"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/15058"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-0016(03)00064-9"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00512-1"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i23.10"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/nmat974"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200006)30:6<1714::AID-IMMU1714>3.0.CO;2-C"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308490100"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0104031"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1039"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.650"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021598"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(92)80655-Z"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022604120952"},{"key":"e_1_2_9_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20048"},{"key":"e_1_2_9_92_1","first-page":"H387","article-title":"Organ-specific endothelial uptake of cationic liposome-DNA complexes in mice","volume":"273","author":"McLean J. W.","year":"1997","journal-title":"Am. J. Physiol."},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6869"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65005-5"},{"key":"e_1_2_9_95_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi002101f"},{"key":"e_1_2_9_96_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.279.5349.377"},{"key":"e_1_2_9_97_1","first-page":"5139","article-title":"Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo","volume":"62","author":"Zitzmann S.","year":"2002","journal-title":"Cancer Res."},{"key":"e_1_2_9_98_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301115"},{"key":"e_1_2_9_99_1","first-page":"4273","article-title":"Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors","volume":"62","author":"Haviv Y. S.","year":"2002","journal-title":"Cancer Res."},{"key":"e_1_2_9_100_1","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2002.0668"},{"key":"e_1_2_9_101_1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI0215223","article-title":"Improving chemotherapeutic drug penetration in tumours by vascular targeting and barrier alteration","volume":"110","author":"Curnis F.","year":"2000","journal-title":"J. Clin. Invest."},{"key":"e_1_2_9_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm720"},{"key":"e_1_2_9_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1101-1194"},{"key":"e_1_2_9_104_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1070200"},{"key":"e_1_2_9_105_1","first-page":"5838","article-title":"Molecular imaging of angiogenesis in nascent vx-2 rabbit tumours using a novel alpha(v)beta(3)-targeted nanoparticle and 1.5 tesla magnetic resonance imaging","volume":"63","author":"Winter P. M.","year":"2003","journal-title":"Cancer Res."},{"key":"e_1_2_9_106_1","first-page":"7400","article-title":"Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy","volume":"63","author":"Pastorino F.","year":"2003","journal-title":"Cancer Res."},{"key":"e_1_2_9_107_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00099.2003"},{"key":"e_1_2_9_108_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.5.2379"},{"key":"e_1_2_9_109_1","first-page":"L794","article-title":"Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs","volume":"278","author":"Christofidou-Solomidou M.","year":"2000","journal-title":"Am. J. Physiol."},{"key":"e_1_2_9_110_1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1096\/fj.00-0022com","article-title":"Cell-selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting","volume":"15","author":"Scherpereel A.","year":"2001","journal-title":"FASEB J."},{"key":"e_1_2_9_111_1","first-page":"4646","article-title":"Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumour vasculature","volume":"58","author":"Ran S.","year":"1998","journal-title":"Cancer Res."},{"key":"e_1_2_9_112_1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0031-6997(24)01426-1","article-title":"Optimizing liposomes for delivery of chemotherapeutic agents to solid tumours","volume":"51","author":"Drummond D. C.","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"e_1_2_9_113_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000069021.56380.E2"},{"key":"e_1_2_9_114_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.009944"},{"key":"e_1_2_9_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(03)00217-7"},{"key":"e_1_2_9_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(01)00306-6"},{"key":"e_1_2_9_117_1","doi-asserted-by":"publisher","DOI":"10.1038\/427695a"},{"key":"e_1_2_9_118_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.081626898"},{"key":"e_1_2_9_119_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342050-00002"},{"key":"e_1_2_9_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-0294(00)00090-X"},{"key":"e_1_2_9_121_1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00001813-199911000-00007","article-title":"Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models","volume":"10","author":"Banadak S.","year":"1999","journal-title":"Anticancer Drugs"},{"key":"e_1_2_9_122_1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0005-2736(02)00659-4","article-title":"Secereted phospholipase A2 as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissue","volume":"1609","author":"Davidson J.","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"e_1_2_9_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(02)03408-7"},{"key":"e_1_2_9_124_1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0005-2736(02)00461-3","article-title":"Synergistic permeability enhancing effect of lysophospholipids and fatty acids on lipid membranes","volume":"1564","author":"Davidson J.","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"e_1_2_9_125_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm031029r"},{"key":"e_1_2_9_126_1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1042\/bj20030582","article-title":"Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity","volume":"377","author":"McIntyre J. O.","year":"2004","journal-title":"Biochem. J."},{"key":"e_1_2_9_127_1","first-page":"7190","article-title":"Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs","volume":"62","author":"Sapra P.","year":"2002","journal-title":"Cancer Res."},{"key":"e_1_2_9_128_1","first-page":"1949","article-title":"Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump","volume":"6","author":"Goren D.","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_9_129_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1991.tb07697.x"},{"key":"e_1_2_9_130_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0435906100"},{"key":"e_1_2_9_131_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209548200"},{"key":"e_1_2_9_132_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm996"},{"key":"e_1_2_9_133_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1021\/mp034002c","article-title":"Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles","volume":"1","author":"Panyam J.","year":"2003","journal-title":"Mol. Pharmaceut."},{"key":"e_1_2_9_134_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867033457412"},{"key":"e_1_2_9_135_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.507"},{"key":"e_1_2_9_136_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.4.2578"},{"key":"e_1_2_9_137_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp034021m"},{"key":"e_1_2_9_138_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt875"},{"key":"e_1_2_9_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(02)02444-3"},{"key":"e_1_2_9_140_1","doi-asserted-by":"publisher","DOI":"10.1080\/713853956"},{"key":"e_1_2_9_141_1","doi-asserted-by":"publisher","DOI":"10.1021\/nl0347334"},{"key":"e_1_2_9_142_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1078192"},{"key":"e_1_2_9_143_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.303.5658.626"},{"key":"e_1_2_9_144_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc025555t"},{"key":"e_1_2_9_145_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.820271214"},{"key":"e_1_2_9_146_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.043307"},{"key":"e_1_2_9_147_1","doi-asserted-by":"publisher","DOI":"10.1038\/85115"},{"key":"e_1_2_9_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(03)00211-6"},{"key":"e_1_2_9_149_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature02388"},{"key":"e_1_2_9_150_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1093783"},{"key":"e_1_2_9_151_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt981"},{"key":"e_1_2_9_152_1","doi-asserted-by":"publisher","DOI":"10.1038\/35038533"},{"key":"e_1_2_9_153_1","doi-asserted-by":"publisher","DOI":"10.1038\/427779a"},{"key":"e_1_2_9_154_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2004.02.011"},{"key":"e_1_2_9_155_1","first-page":"S75","article-title":"Lymphocyte death by cationic polymers: A role for mitochondrion and implications in gene therapy","volume":"91","author":"Murray J. C.","year":"2004","journal-title":"Br. J. Cancer"},{"key":"e_1_2_9_156_1","doi-asserted-by":"publisher","DOI":"10.1080\/10611860310001636908"},{"key":"e_1_2_9_157_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja016288p"},{"key":"e_1_2_9_158_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.200351244"},{"key":"e_1_2_9_159_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v18.i6.50"},{"key":"e_1_2_9_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2004.02.005"},{"key":"e_1_2_9_161_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg374"},{"key":"e_1_2_9_162_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrd707","article-title":"Moving smaller in drug discovery and delivery","volume":"1","author":"La Van D. A.","year":"2002","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.04-2747rev","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fj.04-2747rev","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.04-2747rev","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:03:36Z","timestamp":1761671016000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.04-2747rev"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":161,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1096\/fj.04-2747rev"],"URL":"https:\/\/doi.org\/10.1096\/fj.04-2747rev","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"2004-09-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-11-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-03-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}